Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Dermatology

How NISCS Affects the Body and How It Is Diagnosed

At a Glance

NISCS is an inherited condition caused by disease-causing changes in both copies of CLDN1. It can affect the skin barrier and bile ducts, so diagnosis combines skin and liver findings with genetic testing; jaundiced newborns also need urgent testing for biliary atresia.

To understand Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome (NISCS), it helps to think of the body as a complex building where every “room” needs tight, waterproof seals to keep everything in its proper place. In NISCS, the instructions for making those seals are faulty, leading to the symptoms you see in your child’s skin and liver.

The Biological “Seal”: Claudin-1

The foundation of this condition lies in a gene called CLDN1. This gene provides the blueprint for a protein called claudin-1 [1]. This protein is a primary component of tight junctions—microscopic seals that hold cells together and create barriers throughout the body [2].

  • In the Skin: Claudin-1 acts like the grout between tiles. When it is missing or doesn’t work correctly, the skin’s protective barrier is “leaky.” This allows essential moisture to evaporate and let irritants in, causing the thick, scaly skin known as ichthyosis [2][1].
  • In the Liver: The same protein helps line the bile ducts, the tubes that transport bile (a digestive fluid) out of the liver. Without strong seals, the bile ducts can become inflamed and scarred, a process called sclerosing cholangitis [3][4].

Because this is an autosomal recessive condition, a child only develops NISCS if they inherit a faulty CLDN1 gene from both parents [4].

The Diagnostic Path

Diagnosing NISCS usually begins with what a doctor sees (clinical signs) and is confirmed by looking at the DNA (molecular genetic testing).

Clinical Clues

Doctors look for a specific combination of features [4]:

  1. Skin: Generalized scaling (ichthyosis) present at or shortly after birth.
  2. Liver: Signs of cholestasis (interrupted bile flow), which can include jaundice or elevated liver enzymes.
  3. Hair and Teeth: Sparse hair (hypotrichosis) or hair loss (alopecia), and sometimes unusual tooth shape or number.

Confirming with Genetics

While the clinical signs point the way, molecular genetic testing is used for confirmation. The molecular diagnosis of NISCS requires finding pathogenic (disease-causing) or likely pathogenic variants in both copies of the CLDN1 gene [4][1]. It is important to know that a “variant of uncertain significance” (VUS), a single carrier variant, or a negative panel result does not definitively confirm or exclude the disorder by itself. Genetic counseling can help you interpret these results.

DO NOT WAIT: Ruling Out Biliary Atresia

Urgent Note: When a newborn has persistent jaundice (yellowing of the skin/eyes) and pale or clay-colored stools, doctors must act immediately to rule out a condition called Biliary Atresia (BA). This is a critical step because BA is a surgical emergency, whereas NISCS is managed medically. Waiting for genetic testing for NISCS MUST NOT delay the biliary atresia workup.

Biliary Atresia is a structural defect where the bile ducts outside the liver are completely blocked or missing from birth [5]. If bile cannot leave the liver, it causes rapid, permanent damage.

Why the Urgency?

  • The Kasai Procedure: Infants with Biliary Atresia need a surgery called the Kasai portoenterostomy to create a new path for bile to drain [5].
  • The Clock is Ticking: This surgery is most successful when performed as early as possible—often before 30 to 45 days [6][7]. Every day of delay increases the risk that the baby will eventually need a liver transplant [8][9]. Evaluation must begin immediately.

How Doctors Tell the Difference

Because the symptoms of NISCS and Biliary Atresia can overlap (both cause jaundice and “acholic” or pale-colored stools), doctors use several tools to differentiate them [4]:

  • Ultrasound: To look for a “triangular cord sign” or a missing gallbladder. These findings are suggestive of BA, but a normal ultrasound does not reliably rule it out.
  • Liver Biopsy: To look at the microscopic structure of the liver tissue. This is supportive, rather than definitive.
  • Cholangiogram: An X-ray of the bile ducts, often done during surgery, to see if they are open (patent) or blocked. This is the definitive anatomic test in the appropriate setting.

In NISCS, the bile ducts are typically present but may be scarred or narrowed, whereas in Biliary Atresia, the main ducts are physically blocked or absent [10][11]. Ruling out Biliary Atresia is the first priority to ensure no time is lost if surgery is needed.

Common questions in this guide

What causes neonatal ichthyosis-sclerosing cholangitis syndrome?
NISCS results when a child inherits disease-causing changes in both copies of the CLDN1 gene, one from each parent. These changes impair claudin-1, a protein that helps form protective seals in the skin and bile ducts.
What signs can suggest NISCS in a newborn or child?
Common clues include generalized scaly skin at or soon after birth and signs of cholestasis, such as jaundice or elevated liver enzymes. Sparse hair or hair loss and unusual tooth shape or number can also occur.
How is NISCS confirmed with genetic testing?
Confirmation generally requires molecular testing to find pathogenic or likely pathogenic CLDN1 variants in both copies of the gene. A variant of uncertain significance, a single carrier variant, or a negative panel result alone does not definitively confirm or rule out NISCS; a genetic counselor can help interpret the result.
Why must biliary atresia be checked urgently when a baby has jaundice and pale stools?
Biliary atresia can block or eliminate the bile ducts outside the liver and can rapidly cause permanent liver damage. It may require Kasai portoenterostomy, which works best when performed early, so its evaluation should not wait for NISCS genetic testing.
How do doctors distinguish NISCS from biliary atresia?
Ultrasound and liver biopsy can provide clues, but they do not always settle the diagnosis. In the appropriate setting, a cholangiogram is the definitive anatomic test; NISCS usually has bile ducts that are present but may be scarred or narrowed, whereas biliary atresia involves ducts that are blocked or absent.

Get notified when new evidence is published on Neonatal ichthyosis-sclerosing cholangitis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    CLDN1 Arg81His founder variant causes ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis (ILVASC) syndrome in Moroccan Jews.

    Eskin-Schwartz M, Dolgin V, Didkovsky E, et al.

    Clinical genetics 2024; (105(1)):44-51 doi:10.1111/cge.14432.

    PMID: 37814412
  2. 2

    CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders.

    Arnold KA, Moran MC, Shi H, et al.

    Experimental dermatology 2024; (33(5)):e15084 doi:10.1111/exd.15084.

    PMID: 38711223
  3. 3

    Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.

    Del Zompo F, Crouchet E, Ostyn T, et al.

    Journal of hepatology 2025; (83(6)):1305-1319 doi:10.1016/j.jhep.2025.08.005.

    PMID: 40846184
  4. 4

    Neonatal ichthyosis-sclerosing cholangitis syndrome caused by a novel CLDN1 mutation: a case report and literature review.

    Ghosh U, Agrawal A, Srinivasan VM, et al.

    Clinical and experimental pediatrics 2025; (68(11)):858-867 doi:10.3345/cep.2025.00906.

    PMID: 41035246
  5. 5

    Biliary atresia: Clinical advances and perspectives.

    Nizery L, Chardot C, Sissaoui S, et al.

    Clinics and research in hepatology and gastroenterology 2016; (40(3)):281-287 doi:10.1016/j.clinre.2015.11.010.

    PMID: 26775892
  6. 6

    Age at surgery and native liver survival in biliary atresia: a systematic review and meta-analysis.

    Hoshino E, Muto Y, Sakai K, et al.

    European journal of pediatrics 2023; (182(6)):2693-2704 doi:10.1007/s00431-023-04925-1.

    PMID: 36997770
  7. 7

    The need for early Kasai portoenterostomy: a Western Pediatric Surgery Research Consortium study.

    Kelley-Quon LI, Shue E, Burke RV, et al.

    Pediatric surgery international 2022; (38(2)):193-199 doi:10.1007/s00383-021-05047-1.

    PMID: 34854975
  8. 8

    Real-world Multi-institutional Data From the Midwest Pediatric Surgery Consortium (MWPSC) to Assess the Effect of Delayed Kasai Procedure on Biliary Drainage in Patients With Biliary Atresia.

    Farooqui ZA, Hartman SJ, Stetson AE, et al.

    Journal of pediatric surgery 2025; (60(5)):162250 doi:10.1016/j.jpedsurg.2025.162250.

    PMID: 40023993
  9. 9

    Gut Microbiome: A Potential Modifiable Risk Factor in Biliary Atresia.

    Jain V, Alexander EC, Burford C, et al.

    Journal of pediatric gastroenterology and nutrition 2021; (72(2)):184-193 doi:10.1097/MPG.0000000000002973.

    PMID: 33427793
  10. 10

    [Neonatal sclerosing cholangitis caused by DCDC2 variations in two siblings and literature review].

    Li JQ, Lu Y, Qiu YL, Wang JS

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2018; (56(8)):623-627 doi:10.3760/cma.j.issn.0578-1310.2018.08.013.

    PMID: 30078246
  11. 11

    Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis.

    Grammatikopoulos T, Sambrotta M, Strautnieks S, et al.

    Journal of hepatology 2016; (65(6)):1179-1187 doi:10.1016/j.jhep.2016.07.017.

    PMID: 27469900

This page explains how NISCS can affect a child’s skin and liver and how clinicians investigate it; it is for informational purposes only and does not constitute medical advice. Persistent jaundice or pale stools in a newborn require prompt medical evaluation and should not wait for genetic testing.